Yanbin Xie

Yanbin Xie

Chief Executive Officer chez Ascentawits Pharmaceuticals Ltd.

Fortune : 19 924 $ au 31/03/2024

65 ans
Health Technology
Consumer Services
Commercial Services

Profil

Yanbin Xie is the founder of BeijingWits Medical Consulting Ltd., which was founded in 1997.
She held the title of General Manager from 1997 to 2018.
Dr. Xie is currently the Co-Chief Executive Officer at Ascentawits Pharmaceuticals Ltd.
and has been in this position since 2018.
She is also currently the Director at Beijing Wits Science & Technology Co., Ltd., a position she has held since 1995.
Dr. Xie has previously worked as a Director at Med-Sonics Corp.
and as a Director at BeyondSpring, Inc. from 2016 to 2023.
Dr. Xie obtained a doctorate degree from Shanxi Medical University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/03/2023 5 581 ( 0,01% ) 19 924 $ 31/03/2024

Postes actifs de Yanbin Xie

SociétésPosteDébut
Beijing Wits Science & Technology Co., Ltd. Director/Board Member 01/01/1995
Chief Executive Officer 01/01/2018
Tous les postes actifs de Yanbin Xie

Anciens postes connus de Yanbin Xie

SociétésPosteFin
BEYONDSPRING INC. Director/Board Member 07/07/2023
Chief Executive Officer 01/01/2018
Med-Sonics Corp. Director/Board Member -
Voir l'expérience en détail de Yanbin Xie

Formation de Yanbin Xie

Shanxi Medical University Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Yanbin Xie

Relations

27

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
BEYONDSPRING INC.

Health Technology

Entreprise privées4

Commercial Services

Beijing Wits Science & Technology Co., Ltd.

Med-Sonics Corp.

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Yanbin Xie